https://stock.noler.com/us/stock/martek-biosciences-corp https://stock.noler.com/us/stock/martek-biosciences-corp/accounts-payable https://stock.noler.com/us/stock/martek-biosciences-corp/accounts-receivable https://stock.noler.com/us/stock/martek-biosciences-corp/accrued-liabilities-current https://stock.noler.com/us/stock/martek-biosciences-corp/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/martek-biosciences-corp/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/martek-biosciences-corp/acquisitions https://stock.noler.com/us/stock/martek-biosciences-corp/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/martek-biosciences-corp/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/martek-biosciences-corp/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/martek-biosciences-corp/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities-other https://stock.noler.com/us/stock/martek-biosciences-corp/advertising-expense https://stock.noler.com/us/stock/martek-biosciences-corp/amended-reports-10-k https://stock.noler.com/us/stock/martek-biosciences-corp/amended-reports-10-k405 https://stock.noler.com/us/stock/martek-biosciences-corp/amended-reports-10-q https://stock.noler.com/us/stock/martek-biosciences-corp/amortization https://stock.noler.com/us/stock/martek-biosciences-corp/amortization-of-financing-costs https://stock.noler.com/us/stock/martek-biosciences-corp/aoci https://stock.noler.com/us/stock/martek-biosciences-corp/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/martek-biosciences-corp/basic-shares https://stock.noler.com/us/stock/martek-biosciences-corp/capital-expenditures https://stock.noler.com/us/stock/martek-biosciences-corp/cash-and-equivalents https://stock.noler.com/us/stock/martek-biosciences-corp/cash-flow-breakdown https://stock.noler.com/us/stock/martek-biosciences-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/martek-biosciences-corp/common-stock-value https://stock.noler.com/us/stock/martek-biosciences-corp/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/martek-biosciences-corp/cost-of-goods-sold https://stock.noler.com/us/stock/martek-biosciences-corp/cost-of-revenue https://stock.noler.com/us/stock/martek-biosciences-corp/cost-of-services https://stock.noler.com/us/stock/martek-biosciences-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/martek-biosciences-corp/current-assets https://stock.noler.com/us/stock/martek-biosciences-corp/current-liabilities https://stock.noler.com/us/stock/martek-biosciences-corp/debt-issued https://stock.noler.com/us/stock/martek-biosciences-corp/debt-repaid https://stock.noler.com/us/stock/martek-biosciences-corp/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/martek-biosciences-corp/deferred-revenue https://stock.noler.com/us/stock/martek-biosciences-corp/deferred-revenue-noncurrent https://stock.noler.com/us/stock/martek-biosciences-corp/deferred-tax-assets-net-current https://stock.noler.com/us/stock/martek-biosciences-corp/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/martek-biosciences-corp/depreciation-and-amortization https://stock.noler.com/us/stock/martek-biosciences-corp/diluted-shares https://stock.noler.com/us/stock/martek-biosciences-corp/eps https://stock.noler.com/us/stock/martek-biosciences-corp/eps-basic https://stock.noler.com/us/stock/martek-biosciences-corp/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/martek-biosciences-corp/excess-tax-benefit-from-share-based-compensation-operating-activities https://stock.noler.com/us/stock/martek-biosciences-corp/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/martek-biosciences-corp/financing-cash-flow https://stock.noler.com/us/stock/martek-biosciences-corp/goodwill https://stock.noler.com/us/stock/martek-biosciences-corp/gross-profit https://stock.noler.com/us/stock/martek-biosciences-corp/income-tax https://stock.noler.com/us/stock/martek-biosciences-corp/income-taxes-paid https://stock.noler.com/us/stock/martek-biosciences-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/martek-biosciences-corp/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/martek-biosciences-corp/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/martek-biosciences-corp/increase-decrease-in-inventories https://stock.noler.com/us/stock/martek-biosciences-corp/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/martek-biosciences-corp/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/martek-biosciences-corp/insider-transactions-other https://stock.noler.com/us/stock/martek-biosciences-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/martek-biosciences-corp/insider-transactions-stock-units https://stock.noler.com/us/stock/martek-biosciences-corp/interest-expense https://stock.noler.com/us/stock/martek-biosciences-corp/interest-paid https://stock.noler.com/us/stock/martek-biosciences-corp/inventory https://stock.noler.com/us/stock/martek-biosciences-corp/inventory-write-down https://stock.noler.com/us/stock/martek-biosciences-corp/investing-cash-flow https://stock.noler.com/us/stock/martek-biosciences-corp/investment-income-nonoperating https://stock.noler.com/us/stock/martek-biosciences-corp/long-term-debt https://stock.noler.com/us/stock/martek-biosciences-corp/marketable-securities-current https://stock.noler.com/us/stock/martek-biosciences-corp/net-change-in-cash https://stock.noler.com/us/stock/martek-biosciences-corp/oci-derivatives-qualifying-as-hedges-net-of-tax-change https://stock.noler.com/us/stock/martek-biosciences-corp/oci-derivatives-qualifying-as-hedges-tax https://stock.noler.com/us/stock/martek-biosciences-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/martek-biosciences-corp/oci-reclassification-adjustment-for-write-down-of-securities-net-of-tax https://stock.noler.com/us/stock/martek-biosciences-corp/oci-reclassification-adjustment-for-write-down-of-securities-tax https://stock.noler.com/us/stock/martek-biosciences-corp/oci-unrealized-gain-loss-on-derivatives-arising-net-of-tax https://stock.noler.com/us/stock/martek-biosciences-corp/oci-unrealized-gain-loss-on-derivatives-arising-tax https://stock.noler.com/us/stock/martek-biosciences-corp/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/martek-biosciences-corp/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/martek-biosciences-corp/operating-cash-flow https://stock.noler.com/us/stock/martek-biosciences-corp/operating-expenses https://stock.noler.com/us/stock/martek-biosciences-corp/operating-income https://stock.noler.com/us/stock/martek-biosciences-corp/other-cost-and-expense-operating https://stock.noler.com/us/stock/martek-biosciences-corp/other-current-assets https://stock.noler.com/us/stock/martek-biosciences-corp/other-noncurrent-assets https://stock.noler.com/us/stock/martek-biosciences-corp/other-selling-general-and-administrative-expense https://stock.noler.com/us/stock/martek-biosciences-corp/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/martek-biosciences-corp/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/martek-biosciences-corp/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/martek-biosciences-corp/payments-to-acquire-investments https://stock.noler.com/us/stock/martek-biosciences-corp/preferred-shares-facts https://stock.noler.com/us/stock/martek-biosciences-corp/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/martek-biosciences-corp/preferred-stock-shares-authorized https://stock.noler.com/us/stock/martek-biosciences-corp/preferred-stock-shares-issued https://stock.noler.com/us/stock/martek-biosciences-corp/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/martek-biosciences-corp/preferred-stock-value https://stock.noler.com/us/stock/martek-biosciences-corp/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/martek-biosciences-corp/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/martek-biosciences-corp/proceeds-from-long-term-lines-of-credit https://stock.noler.com/us/stock/martek-biosciences-corp/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/martek-biosciences-corp/profit-loss https://stock.noler.com/us/stock/martek-biosciences-corp/property-plant-equipment https://stock.noler.com/us/stock/martek-biosciences-corp/public-float https://stock.noler.com/us/stock/martek-biosciences-corp/repayments-of-long-term-lines-of-credit https://stock.noler.com/us/stock/martek-biosciences-corp/research-and-development https://stock.noler.com/us/stock/martek-biosciences-corp/restructuring-charges https://stock.noler.com/us/stock/martek-biosciences-corp/retained-earnings https://stock.noler.com/us/stock/martek-biosciences-corp/revenue https://stock.noler.com/us/stock/martek-biosciences-corp/sales-revenue-goods-net https://stock.noler.com/us/stock/martek-biosciences-corp/sales-revenue-services-net https://stock.noler.com/us/stock/martek-biosciences-corp/sec-comment-letters-corresp https://stock.noler.com/us/stock/martek-biosciences-corp/sec-comment-letters-upload https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-10-k https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-10-k405 https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-10-q https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-11-k https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-15-12g https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-25-nse https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-8-k https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-ars https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-ct-order https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-def-14a https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-pre-14a https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-regdex https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-sc-14d9 https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-sc-to-c https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-sc-to-t https://stock.noler.com/us/stock/martek-biosciences-corp/sec-filings-sc14d9c https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-424b7 https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-effect https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-rw https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/martek-biosciences-corp/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/martek-biosciences-corp/shares-authorized https://stock.noler.com/us/stock/martek-biosciences-corp/shares-issued https://stock.noler.com/us/stock/martek-biosciences-corp/short-term-debt https://stock.noler.com/us/stock/martek-biosciences-corp/stock-based-compensation https://stock.noler.com/us/stock/martek-biosciences-corp/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/martek-biosciences-corp/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/martek-biosciences-corp/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/martek-biosciences-corp/total-assets https://stock.noler.com/us/stock/martek-biosciences-corp/total-liabilities https://stock.noler.com/us/stock/martek-biosciences-corp/total-liabilities-and-equity